SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-036948
Filing Date
2022-02-11
Accepted
2022-02-11 16:02:07
Documents
13
Period of Report
2022-02-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d467470d8k.htm   iXBRL 8-K 25023
2 EX-99.1 d467470dex991.htm EX-99.1 65052
  Complete submission text file 0001193125-22-036948.txt   228709

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dcph-20220208.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20220208_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20220208_pre.xml EX-101.PRE 10818
7 EXTRACTED XBRL INSTANCE DOCUMENT d467470d8k_htm.xml XML 3221
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 22620601
SIC: 2834 Pharmaceutical Preparations